Mild cognitive impairments in patients in the acute period of cardioembolic stroke

Cover Page


Cite item

Abstract

Aim – to study the features of moderate cognitive disorders in patients with acute ischemic stroke of the cardioembolic subtype during comprehensive neuropsychological testing in comparison with data on structural changes in brain tissue identified using visual semi-quantitative scales during magnetic resonance imaging of the brain.

Material and methods. The prospective observational study involved 60 patients (22 women and 38 men) diagnosed with cardioembolic stroke. The study participants were divided into two groups: patients with non-amnesic (neurodynamic) multifunctional type of moderate cognitive disorders (40 patients: 70% men, 30% women, mean age 64.3 years) and patients with amnestic multifunctional type (20 patients: 50% men, 50% women, mean age 76.1 years). All patients underwent a comprehensive neuropsychological examination and magnetic resonance imaging of the brain using standard magnetic resonance scales.

Results. Patients with non-amnestic multifunctional type of moderate cognitive disorders accounted for 67% of the examined patients (40 people), and 33% (20 people) were patients with amnestic multifunctional type. During the examination, neuropsychological features were identified in each group. 22% of patients (13 people) had infarctions in the “strategic” zones, and 45% of patients (27 people) had multiple focal ischemic strokes. In 90% of patients (54 people), there was a pronounced lesion of the white matter in the form of a hyper-intense signal from the periventricular and subcortical areas and a moderate widening of the cerebral sulci against the background of slight atrophy of the gyri.

Conclusion. The comprehensive diagnostic approach, including neuropsychological testing and assessment of structural changes in the brain using visual semi-quantitative magnetic resonance scales, allows for the detection of cognitive impairments at the pre-dementia stage and the initiation of therapy aimed at preventing the progression of these impairments.

Full Text

INTRODUCTION

Cardioembolic stroke is one of the most prevalent subtypes of ischemic stroke. In its acute phase, some syndromes may develop that preclude effective rehabilitation. These include cognitive impairments that have a significant adverse effect on the quality of life and reduce the possibilities of social and household adaptation. At the same time, the clinical patterns of the higher cortical functions have not been fully identified to this day. In the diagnostic algorithm of acute cerebrovascular accidents (ACVA), magnetic resonance imaging (MRI) has an important role. Semi-quantitative visual scales were developed to improve quality of assessment of findings of structural MRI and objectification of the obtained data. However, comparison of results of changes of the brain matter identified using such scales with the developing cognitive disorders has not been carried out in to a sufficient extent. Identification of some correlations of these indicators would facilitate a better understanding of impairments of the higher cortical functions from the perspective of the theory on their dynamic localization, and would improve the quality of prediction of their condition in remote periods of ACVA.

The term “mild cognitive impairment” was first used by the American neurologist R.C. Petersen in 1997 to characterize an interim stage between the normal aging and dementia [1]. A mild cognitive impairment (MCI) is a clinically significant deterioration of cognitive functions (attention, memory, speech, perception, praxis, executive functions) that has not reached the degree of dementia [2]. At this level of impairment of higher cortical functions, complete maladaptation of patients and loss of independence in daily life are not observed. Prevalence of MCI among people aged 60 and above varies from 5.0 to 36.7% [3]. The rate of MCI progression to dementia is approx. 8-15% per year [4]. The following are identified as the major diagnostic criteria of MCI: deterioration of the higher cortical functions vs. individual baseline level, complaints of impairment of memory, attention and other cognitive functions that come both from the patient and from the informants (relative or a person close to the patient), or from the consulting physician. The functional impairment is confirmed by neuropsychological tests or other clinical measurement. The impairment may involve one or more cognitive spheres. Some independence in the daily life may remain but theme may be minor difficulties in the performance of complex tasks, however, the level of alterations observed is below the level of dementia. Besides, these impairments manifest on the background of a clear mind, lack of delirium and other psychic disorders [5–7].

In 2014, R.C. Petersen identified 4 types of MCI: amnestic mono-functional; amnestic multifunctional; non-amnestic (neuro-dynamic) mono-functional; non-amnestic multifunctional [8]. Prof. O.S. Levin, in his turn, suggested the amnestic type with memorizing impairment, neuro-dynamic-dysregulatory type with the development of a fronto-subcortical syndrome; the type predominated by visuospatial impairments; the type predominated by language impairments; and the combined type of observed MCI [9, 10].

According to the Russian studies, the most prevalent type of MCI is the non-amnestic multifunctional type [11]. It also follows from literature that 68% of MCIs stem from dyscirculatory encephalopathy or earlier ACVA [12]. It is to be noted that neuropsychological examination of cognitive functions that allows assessment of their different components, is the gold standard of determining the MCI type [13].

AIM

To study the features of moderate cognitive impairments in patients with acute ischemic stroke of the cardioembolic subtype during comprehensive neuropsychological testing in comparison with data on structural changes in brain tissue identified using visual semi-quantitative scales during magnetic resonance imaging of the brain.

MATERIAL AND METHODS

The prospective observation study conducted at the Almazov National Medical Research Centre included 60 patients (22 women and 38 men). Inclusion criteria: acute period of cardioembolic subtype ischemic stroke (diagnosed as per criteria established in the 2024 clinical recommendations); mild cognitive impairments as per diagnostic criteria of the National Institute of Aging and Alzheimer’s Association, ICD-11 criteria, DSM-5; normal consciousness; general stable condition, including compensated chronic diseases; informed consent to participate in the study. Exclusion criteria: known earlier diagnosis that could have been a possible cause of cognitive disorders (Alzheimer’s disease, dementia with Lewy bodies, Pick disease, frontotemporal dementia, Parkinson’s disease, Huntington’s disease, Wilson-Konovalov’s disease and other diseases); speech impairments including aphasia of varying severity; manifested dysarthria; presence of traumatic brain injury; history of alcoholism; surgery within one year prior to inclusion in the study (except emergency endovascular thrombectomy and thromboaspiration on admission); clinically manifested depression or anxiety. To exclude the functional causes of cognitive disorders, a screening for anxiety and depression was performed using the Hamilton’s scale. The finding of this test in the study group did not reach threshold values and matched the normal emotional background.

The study was performed on day 10-14 from the onset of stroke. The patients were divided in two groups. Group I: patients with non-anamnestic (neuro-dynamic) multifunctional MCI. Group II: patients with amnestic multifunctional type or multifunctional type with hippocampal-type memory impairments.

The division of patients into groups was performed based on complaints of memory impairments, particularly, disorders in memorizing new information, and on results of tests focusing on differential diagnostics of MCI types (the 5 word test, free and cued selective reminding test (FCSRT), verbal fluency test (phonetic and semantic associations), trail-making test.

All patients underwent the following assessments: collection of cognitive complaints, medical and life history; neurological examination; evaluation using clinical scales commonly applied in neurological practice to assess stroke severity, functional limitations, and post-stroke disability (National Institutes of Health Stroke Scale, Barthel Index, Modified Rankin Scale, Rivermead Mobility Index, Glasgow Outcome Scale); comprehensive neuropsychological testing; brain MRI with application of MR scales for assessing brain tissue condition.

The neuropsychological testing included a mini-mental scale examination (MMSE) Montreal cognitive assessment, frontal assessment battery test (FAB), clock drawing test, 5 word test, verbal fluency test (phonetic and semantic associations), Mattis dementia rating scale, digit span test, Hamilton anxiety and depression rating scales, symbol digit modalities test, Schulte table test, free and cued selective reminding test (FCSRT) [21–33].

The brain MRI identified the following: localization and volume of the focus of the ischemic stroke, lesion of the areas strategically important for the higher cortical functions, multi-focal lesion of the brain. To assess white matter changes, the Fazekas, Scheltens and Wahlund scales were used. The presence of selective cerebral atrophy or gray matter pathology was evaluated using the following scales: the medial temporal lobe atrophy (MTA) scale, the Koedam parietal atrophy scale and the global cortical atrophy (GCA) scale [34, 40].

Statistical processing of the data was performed in the RStudio integrated development environment. To describe the data, the following descriptive statistics methods were used: for the data with normal or near-normal distribution, mean value and standard deviation were calculated; for the data with distribution significantly different from normal, mean value and standard deviation were augmented with median and values of first and third quartiles (with bootstrapping). Distribution was assessed by constructing histograms. Histograms are presented for data with distributions significantly deviating from normality. For comparing values between MCI types, the two-sample Mann–Whitney U test with Holm’s correction for multiple comparisons was applied. Boxplots were constructed for measures showing significant differences between types.

RESULTS

Clinical and neuropsychological characteristics

According to the patient history data, arterial hypertension and atrial fibrillation was found in all patients of the study sample. 28 patients (42%) had chronic heart failure, and 14 patients (21%) had type II diabetes mellitus. According to the lipid profile, 59 patients (89%) had dyslipidemia. According to the medical documents, 42 patients (64%) had been diagnosed with ‘dyscirculatory encephalopathy’ of various severity prior to the development of the stroke. The evaluation of the neurological status revealed the following: motor impairments, hemiparesis in 60 (91%) patients, sensory impairments in 29 (44%) patients, speech impairments such as dysarthria or volume disorders in 24 (36%) patients, dysfunction of cerebral nerves such as oculomotor disorders, asymmetry and sensory impairments of the face, dysphagia in 33 (50%) patients. The Doppler ultrasonic examination of the brachycephalic arteries and vessels of the head identified atherosclerotic lesion of the brachycephalic vessels (common and internal carotid arteries) in 66 patients (100%). At the same time, hemodynamically significant stenosis over 50% were not identified in the study sample.

The neurological examination found that the average score on the NIHSS scale matched that of mildly severe ischemic stroke. In the vast majority of cases, motor, sensory and coordination disorders were found. In the evaluation of mobility, degree of activity impairment and disability it was found that the patients were able to move about the hospital department without any aids, had mild to moderate activity impairments and were capable of taking care of themselves without assistance. The average score on the Hachinski scale shows that clinical signs of vascular cognitive disorders prevailed in the patients included in the study. Some individual cases demonstrated possible presence of a neurodegenerative component. In the evaluation of the patient mobility by the Rivermead index it was found, that mild impairment of mobility was prevalent in the studies cohort. The study of functional activity using the Barthel scale demonstrated mild to moderate dependence degrees. On the whole, these data matched the results of Rankin scale examination (mild to moderate activity impairments). The testing on the Glasgow outcome scale also correlated with these findings. The general values follow in Table 1.

 

Table 1. Clinical and neurological characteristics of patients with MCI in the acute period of cardioembolic stroke on days 10-14 (in points, M±SD, median (Q1–Q3))

Таблица 1. Клинико-неврологическая характеристика пациентов с УКР в остром периоде кардиоэмболического инсульта на 10–14 сутки (в баллах, M±SD, медиана (Q1–Q3))

Parameter

M±SD

Median (Q1–Q3)

Age

68,23 ± 11,24

-

NIHSS

3,33 ± 2,57

2,50 (2,00–4,00)

Rivermead

10,10 ± 3,85

11,00 (7,00–14,00)

Rankin

2,83 ± 0,81

-

Barthel

78,50 ± 23,87

90,00 (65,00–95,00)

Hachinski

9,83 ± 1,24

-

Glasgow outcome scale

4,20 ± 0,58

-

Notes: NIHSS – The National Institutes of Health Stroke Scale

Примечания: NIHSS – The National Institutes of Health Stroke Scale.

 

In the evaluation of the neuropsychological status, 100% patients (n=60) came up with cognitive complaints. These included lowered attention focus, quick fatigue when performing cognitive tasks, easy distraction, abstraction, longer time needed to perform a specific action, forgetfulness, lowered thinking rate. The neurological tests identified the following cognitive disorders most often: lowered attention focus, some instability and exhaustion of attention, reduced verbal fluency, deterioration of constructive and dynamic praxis, lower quality of regulatory functions, executive skills, lowered psychomotor rate without impairment of thinking structure, deterioration of short-term memory, mild disorders of the visuospatial gnosis. The cumulative data of the results of neuropsychological examination follow in Table 2.

 

Table 2. Results of neuropsychological examination of patients with MCI in the acute period of cardioembolic stroke (in points, M±SD, median (Q1–Q3))

Таблица 2. Результаты нейропсихологического обследования пациентов с УКР в остром периоде кардиоэмболического инсульта (в баллах, M±SD, медиана (Q1–Q3))

Test

M±SD

Median (Q1–Q3)

Mattis dementia rating scale (MDRS), total

121,72 ± 6,29

25,00 (25,00–26,25)

MDRS, initiation – perseveration

29,40 ± 3,60

-

MDRS, attention

31,22 ± 2,50

-

MDRS, constructive praxis

5,00 ± 0,71

-

MDRS, conceptualization

34,55 ± 1,78

-

MDRS, memory

21,47 ± 2,27

-

MMSE

25,52 ± 1,08

-

FAB

14,65 ± 1,78

-

Clock drawing test

9,48 ± 0,85

10,00 (9,00–10,00)

Digit span test

25,37 ± 8,84

-

MoCA

23,90 ± 1,87

24,00 (23,00–25,00)

Schulte table No.1

65,17 ± 10,22

-

Schulte table No.2

65,75 ± 10,37

-

Schulte table No.3

65,85 ± 11,14

-

Schulte table No.4

65,77 ± 10,83

-

Schulte table No.5

66,58 ± 10,64

-

Direct numbers

4,82 ± 0,39

5,00 (5,00–5,00)

Reverse numbers

3,80 ± 0,40

4,00 (4,00–4,00)

FCSRT (free reminding)

18,08 ± 3,72

-

FCSRT (cued reminding)

13,33 ± 3,94

-

Notes: MDRS – Mattis dementia rating scale, MMSE – mini-mental status evaluation, МоСА – Montreal scale of cognitive assessment, FAB – frontal dysfunction battery of tests.

Примечания: ШДМ – шкала деменции Маттиса, MMSE – краткая шкала оценки психического статуса, МоСА – Монреальская шкала оценки когнитивных функций, FAB – батарея тестов лобной дисфункции.

 

Based on the analysis of complaints, analysis of life and disease history, and data of complex neurological assessment, the patients were divided into two groups. The patients with non-amnestic (neuro-dynamic) multifunctional MCI (nMCI) comprised 67% of the patients (n=40); while 33% (20 patients) had amnestic multifunctional MCI (aMCI) or multifunctional MCI with hippocampal-type memory impairments. The data follow in Table 3.

 

Table 3. Comparative analysis of neuropsychological test data in two groups (in points, M±SD, median (Q1–Q3))

Таблица 3. Сравнительный анализ данных нейропсихологического тестирования в двух группах (в баллах, M±SD, медиана (Q1–Q3))

Test

Dysregulatory type

Amnestic type

M±SD

Median

M±SD

Median

5 word test (immediate recall)

(Q1–Q3)

4,50 (4,00–5,00)

(Q1–Q3)

4,00 (3,00–4,00)

5 word test (cued immediate recall)

4,70 ± 0,52

5,00 (4,00–5,00)

4,40 ± 0,68

4,50 (4,00–5,00)

5 word test (delayed recall)

3,17 ± 0,75***

3,00 (3.00–4,00)

1,85 ± 0,99

2,00 (1,75–2,25)

5 word test (cued delayed recall)

3,92 ± 0,76*

4,00 (3,00–4,00)

3,20 ± 0,95

3,00 (2,75–4,00)

Trail-making test, part A

64,42 ± 10,30

66,00 (59,50–69,75)

71,70 ± 10,31

70,50 (65,75–77,25)

Trail-making test, part B

65,90 ± 10,81

68,00 (61,00–72,00)

72,00 ± 10,50

72,00 (65,75–77,25)

Phonetic association test

9,57 ± 1,81*

10,00 (8,00–11,00)

8,00 ± 1,95

7,50 (7,00–9,00)

Semantic association test

12,62 ± 2,22*

12,50 (11,00–15,00)

10,45 ± 2,46

10,00 (9,00–12,00)

FCSRT (free reminding)

19,75 ± 2,73

20,00 (17,75–22,00)

14,75 ± 3,18

15,00 (11,75–17,25)

FCSRT (cued reminding)

15,05 ± 3,57

16,00 (13,00–18,00)

9,90 ± 1,86

10,00 (8,00–12,00)

FCSRT, total score

34,80 ± 4,16***

35,00 (31,75–38,00)

24,65 ± 3,18

25,00 (22,75–27,00)

Notes: * – p<0.05, ** – p<0.01, *** – p<0.001, FCSRT – free and cued selective reminding test.

Примечания: * – p<0,05, ** – p<0,01, *** – p<0,001, FCSRT – тест ассоциированного селективного распознавания.

 

Patients with amnestic multifunctional MCI performed worse in neuropsychological tests that assessed memory and memory-associated activities. The group comparison showed the following specifics: in patients with aMCI there were disorders in the information memorizing process, which manifested in difficulties in delayed recall of words. Cues were of little assistance. This group also showed deterioration of visuospatial functions, which manifested in disorders in the clock drawing test and methods involving copying of material. In patients with nMCI, the differences in the immediate and delayed recall of words were less manifested, and the semantic cue usually helped recall the stimulus material. The charts of value distribution in the study samples are shown in Fig. 1.

 

Figure 1. Boxplots comparing the neuropsychological examination data of the two identified variants of MCI.

Рисунок 1. Диаграммы размаха сравнения данных нейропсихологического обследования двух выявленных вариантов УКР.

 

In 22% of patients (n=13) with mild cognitive impairments, infarctions were detected in some areas of the ‘strategic’ zones such as thalamus, striatum, hippocampus, prefrontal cortex, left temporo-parieto-occipital junction; in 45% of patients (n=27), multifocal brain lesions in the form of ischemic stroke were detected. This patient group is characterized by fairly pronounced white matter lesions appearing as hyperintensities in the periventricular and subcortical regions. These lesions are represented by numerous foci of varying diameters, typically distributed across all cerebral lobes, sometimes showing a tendency to coalesce. This group also exhibits moderate sulcal widening with mild gyral atrophy. When using the Fazekas scale, it was determined that 90% of patients (n=54) exhibited moderate white matter lesions, corresponding to a score of 3 or 4 points. This group was characterized by the presence of leukoaraiosis foci along the cerebral ventricles, as well as diffusely distributed gliosis areas appearing as hyperintense signals. These changes generally matched the data obtained in the analysis of MRI scans using the Wahlund scale, where the local alteration foci prevail sometimes showing a tendency to coalesce. The vast majority of these changes was localized in the frontal lobes, and, to a lesser degree, in the parietal and temporal lobes. At the same time, the use of the Scheltens scale demonstrated a more pronounced degree of white matter lesion, which reflects the specifics of interpretation of results on this scale and the emphasis on the quantitative assessment of foci. The analysis of results of parietal lobe lesions on the Koedam scale generally revealed moderate atrophy of the gyri of the lobes, accompanied with some widening of the sulci (1 point). In some cases, not changes were found. In individual cases, severe atrophy was identified that came up to 2 points. The analysis of alterations in the medial section of the temporal lobe using the MTA scale identified no pronounced alterations in any of the cases. In individual examinations, no significant atrophy was found. For the majority of patients, the characteristic features were the mild dilatation of the chorioidal fissure (1 point) or a minor reduction in the height of the hippocampus accompanied by slight enlargement of the temporal horns of the lateral ventricles (2 points). The assessment using the GCA scale revealed that for the majority of the examined patients a minor atrophy of the cerebral matter (10 points or less) was characteristic. The atrophies were represented with some widening of the sulci and ventricles and some loss of volume of the gyri. A small number of patients demonstrated moderate atrophic changes, ranging from 11 to 20 points on the applied scale. These changes primarily affected the frontal regions, to a lesser extent the temporal areas and the parieto-occipital regions. The overall data from the brain assessment using MR scales are presented in Table 4.

 

Table 4. MR scale data in the study group of patients with MCI

Таблица 4. Данные МР-шкал в исследуемой группе пациентов с УКР

МР scale

Average score

Fazekas

3,35

Scheltens

18,94

Wahlund

12,75

Medial Temporal lobe Atrophy (МТА)

1,41

Koedam

1,11

Global Cortical Atrophy (GCA)

7,65

 

DISCUSSION

The neuropsychological assessment revealed that patients with MCI following cardioembolic stroke primarily develop neurodynamic and dysregulatory impairments. These deficits are associated with damage to the 1st and 3rd structural-functional blocks, according to A.R. Luria’s theory of higher cortical function organization [14]. Thic MCI type is usually represented with disorders in the programming, regulation and control over the progression of psychic activity, processes of formation of intentions, goals of psychic activity, regulation and control of actions including behavior, disorders of attention, motivation, decrease of speed of psychic processes with the development of bradyphrenia [15]. The development of these impairments is based on either a fronto-subcortical syndrome (primary or secondary frontal lobe pathology) or a disconnection phenomenon [8, 16]. Such cases may also demonstrate deterioration of short-term memory and formation of a nonspecific forgetfulness with preserved recognition and mediated memorizing [15, 17, 18]. For amnestic impairments, hippocampal-type memory dysfunctions, long-term memory, primary memorizing of new information (true amnesia) or recognition are characteristic [15, 18]. Such impairments stem from lesions of hippocampal structures and its connections [18–20]. This type of MCIs may indicate a pre-dementia (preclinical) stage of Alzheimer’s disease [20]. The assessment of cerebral changes using visual MR scales, mildly pronounced atrophic changes of the white and the gray matter are observed. Al the same time, lesions of the frontal lobes prevail as well as those of subcortical structures, which also characterized the development of fronto-subcortical syndrome and aligns with findings of neuropsychological examination. In some cases, atrophic changes in the hippocampal area and in the mediobasal structures of temporal lobes were detected. In the clinical picture, they were combined with hippocampal-type memory impairments. This may indicate that these patients have a competing neurodegenerative process and formation of mixed cognitive disorders. Identification of atrophic changes in the parietal lobes was less frequent. Quite expectedly, according to fundamentals of functional neuroanatomy, these patients demonstrated formation of visuospatial impairments that was combined with neuro-dynamic and dysregulatory impairments.

CONCLUSION

A comprehensive diagnostic approach involving careful collection of complaints and history, neuropsychological testing and assessment of structural brain changes using visual semi-quantitative MR scales facilitates detection of cognitive impairments at the pre-dementia stage and identification of their potential anatomical substrate. This approach assists implementation of optimal therapeutic approaches to their treatment and prevention of progression to the stage of dementia. Determination of the amnestic type of MCI may indirectly indicate an alternative pathological process such as pre-dementia stage of the Alzheimer’s disease, which enables direction of the patient for further examination to confirm or exclude this condition.

Thus, the identification of mild cognitive impairments (MCI) in patients during the acute phase of ischemic stroke enables neurologists to formulate appropriate recommendations for the subsequent rehabilitation period, with a focus on the correction of higher cortical function deficits.

ADDITIONAL INFORMATION

Ethics approval. Extract No. 160210-23 from the minutes of the LEC meeting No. 0210-23 dated October 30, 2023.

Consent for publication: All patients signed a written informed consent form.

Study funding. The study was carried out as part of the State Task «Development of a method for early diagnosis of hidden neurodegenerative changes in patients with acute ischemic stroke».

Conflict of interest. The author declares that there are no obvious or potential conflicts of interest associated with the content of this article.

Statement of originality. No previously published material (text, images, or data) was used in this work.

Data availability statement. The editorial policy regarding data sharing does not apply to this work.

Generative AI. No generative artificial intelligence technologies were used to prepare this article.

Provenance and peer review. This paper was submitted unsolicited and reviewed following the standard procedure. The peer review process involved 2 external reviewers.

×

About the authors

Kristina M. Shubina

Almazov National Medical Research Centre

Author for correspondence.
Email: krisschubina@yandex.ru
ORCID iD: 0000-0002-7336-3860

Neurologist, Research Laboratory Technician at the Scientific Research Laboratory of Neurology and Neurorehabilitation, Postgraduate Student of the Department of Neurology

Russian Federation, Saint Petersburg

References

  1. Petersen RC, Touchon J. Consensus on mild cognitive impairment. Research and practice in AD. EADS-ADCS. Research and Practice in Alzheimer’s Disease. 2005;10:38-46. URL: https://mayoclinic.elsevierpure.com/en/publications/consensus-on-mild-cognitive-impairment-eadc-adcs
  2. Clinical guidelines “Cognitive Disorders in the Elderly and Senile Population” (approved by the Ministry of Health of the Russian Federation). M., 2024. (In Russ.). [Клинические рекомендации «Когнитивные расстройства у лиц пожилого и старческого возраста» (одобрено Министерством здравоохранения Российской Федерации). М., 2024].
  3. Sachdev PS, Lipnicki DM, Kochan NA, et al. The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS One. 2015;10(11):e0142388. doi: 10.1371/journal.pone.0142388
  4. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):257-262. doi: 10.1016/j.jalz.2011.03.004
  5. Diagnostic and statistical manual of mental disorders. URL: www.dsm5.org/Pages/Default.aspx
  6. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter. Early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-1142. doi: 10.1212/wnl.56.9.1133
  7. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008;13(1):45-53. DOI: https://doi.org/10.1017/s1092852900016151
  8. Levin OS. Pre-Dementia Neurocognitive Disorders in the Elderly. S.S. Korsakov Journal of Neurology and Psychiatry. Special Issues. 2019;119(9-2):10-17. [Левин О.С. Преддементные нейрокогнитивные нарушения у пожилых. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2019;119(9-2):10-17]. doi: 10.17116/jnevro201911909210
  9. Vasenina EE, Gutorova DA, Smirnova IM, Levin OS. Pre-Dementia Cognitive Disorders: Modern Approaches to Terminology, Diagnostics, and Treatment. Farmateka. 2018;14:8-16. [Васенина Е.Е., Гуторова Д.А., Смирнова И.М., Левин О.С. Додементные когнитивные расстройства: современные подходы к терминологии, диагностике и лечению. Фарматека. 2018;14:8-16]. DOI: https://dx.doi.org/10.18565/pharmateca.2018.14.8-16
  10. Levin OS. Cognitive impairments in the practice of a neurologist. M, 2006. [Левин О.С. Когнитивные нарушения в практике невролога. М., 2006].
  11. Grishina DA, Lokshina AB. Moderate cognitive disorders: some aspects of diagnosis and therapy. Doctor.Ru. 2021;20(5):20-25. [Гришина Д.А., Локшина А.Б. Умеренные когнитивные расстройства: некоторые аспекты диагностики и терапии. Доктор.Ру. 2021;20(5):20-25]. doi: 10.31550/1727-2378-2021-20-5-20-25
  12. Yakhno NN, Preobrazhenskaya IS, Zakharov VV, et al. Prevalence of cognitive impairments in neurological diseases (analysis of specialized outpatient visits). Neurology, Neuropsychiatry, Psychosomatics. 2012;2:30-34. [Яхно Н.Н., Преображенская И.С., Захаров В.В., и др. Распространенность когнитивных нарушений при неврологических заболеваниях (анализ работы специализированного амбулаторного приема). Неврология, нейропсихиатрия, психосоматика. 2012;2:30-34]. doi: 10.14412/2074-2711-2012-378
  13. Alfano DP, Grummisch JA, Gordon JL, Hadjistavropoulos T. A Neuropsychological approach to mild cognitive impairment. Archives of Clinical Neuropsychology. 2022;37(5):873-890. doi: 10.1093/arclin/acac026
  14. Luria AR. Higher cortical functions of man. SPb., 2008. (In Russ.). [Лурия А.Р. Высшие корковые функции человека. СПб., 2008].
  15. Levin OS. Diagnosis and treatment of cognitive impairment and dementia in clinical practice. M., 2019. (In Russ.). [Левин О.С. Диагностика и лечение когнитивных нарушений и деменции в клинической практике. М., 2019].
  16. Zueva IB, Kim YuV, Krivonosov DS, Samantsova TV. Cognitive, emotional and neurodynamic disorders in middle-aged hypertension patients: the opportunities of citicoline therapy. Effective Pharmacotherapy, 2023;19(54):12-19. [Зуева И.Б., Ким Ю.В., Кривоносов Д.С., Саманцова Т.В. Когнитивные, эмоциональные и нейродинамические нарушения у пациентов с артериальной гипертензией среднего возраста: возможности терапии цитиколином. Эффективная фармакотерапия. 2023;19(54):12-19]. DOI: https://doi.org/10.33978/2307-3586-2023-19-54-12-19
  17. Emelin AYu. Cognitive impairments in cerebrovascular disease. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(4):11-18. [Емелин А.Ю. Когнитивные нарушения при цереброваскулярной болезни. Неврология, нейропсихиатрия, психосоматика. 2014;6(4):11-18]. DOI: https://doi.org/10.14412/2074-2711-2014-4-11-18
  18. Zakharov VV. Memory types and clinical syndromes of amnestic disorders. Behavioral Neurology. 2022;1:18-26. [Захаров В.В. Виды памяти и клинические синдромы амнестических расстройств. Поведенческая неврология. 2022;1:18-26]. doi: 10.46393/27129675_2022_1_18
  19. Levin OS. Moderate Cognitive Disorder: Diagnosis and Treatment. Effektivnaya farmakoterapiya. Nevrologiya i psyhiatriya. 2012;5:14-20. (In Russ.). [Левин О.С. Умеренное когнитивное расстройство: диагностика и лечение. Эффективная фармакотерапия. Неврология и психиатрия. 2012;5:14-20]. URL: https://umedp.ru/articles/umerennoe_kognitivnoe_rasstroystvo_diagnostika_i_lechenie.html
  20. Tabeeva GR. Neurocognitive aging and cognitive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(6):160-167. [Табеева Г.Р. Нейрокогнитивное старение и когнитивные расстройства. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(6):160-167]. DOI: https://doi.org/10.17116/jnevro2019119061160
  21. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6
  22. Kurbanova MM, Galaeva AA, Stefanovskaya EV, et al. Modern methods for the diagnosis of cognitive impairment. Russian Family Doctor. 2020;24(1):35-44. [Курбанова М.М., Галаева А.А., Стефановская Е.В., и др. Современные методы диагностики когнитивных нарушений. Российский семейный врач. 2020;24(1):35-44. doi: 10.17816/RFD18986
  23. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-6. DOI: https://doi.org/10.1212/wnl.55.11.1621
  24. Nishiwaki Y, Breeze E, Smeeth L, et al. Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol. 2004;160(8):797-807. doi: 10.1093/aje/kwh288
  25. Mormont E, Jamart J, Robaye L. Validity of the five-word test for the evaluation of verbal episodic memory and dementia in a memory clinic setting. J Geriatr Psychiatry Neurol. 2012;25(2):78-84. doi: 10.1177/0891988712445088
  26. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5:135-140. doi: 10.1016/0028-3932(67)90015-2
  27. Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol. 1995;52(9):899-904. doi: 10.1001/archneur.1995.00540330081018
  28. Wechsler D. A Standardized Memory Scale for Clinical Use. The Journal of Psychology. 1945;19(1):87-95. doi: 10.1080/00223980.1945.9917223
  29. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45(8):742-747. doi: 10.1001/archpsyc.1988.01800320058007
  30. Kiely KM, Butterworth P, Watson N, Wooden M. The Symbol Digit Modalities Test: Normative data from a large nationally representative sample of Australians. Arch Clin Neuropsychol. 2014;29(8):767-75. doi: 10.1093/arclin/acu055
  31. Rubinstein SYa. Experimental methods of pathopsychology. M., 1999. (In Russ.). [Рубинштейн С.Я. Экспериментальные методики патопсихологии. М., 1999].
  32. Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276. doi: 10.2466/pms.1958.8.3.271
  33. Ivnik RJ, Smith GE, Lucas JA, et al. Free and cued selective reminding test: MOANS norms. J Clin Exp Neuropsychol. 1997;19(5):676-91. doi: 10.1080/01688639708403753
  34. Fazekas F, Cavluk JB, Alavi A, et al. Abnormalities of MRI signal at 1.5 T in Alzheimer’s dementia and normal aging. American Journal of Roentgenology. 1993;149(2):351-6. doi: 10.2214/ajr.149.2.351
  35. Scheltens P, Barkhof F, Leys D, et al. A semi-quantitative rating scale for the assessment of signal hyperintensity in magnetic resonance imaging. Journal of Neurological Sciences. 1993;114:7-12. doi: 10.1016/0022-510x(93)90041-v
  36. Crum RM, Anthony JC, Bassett SS, et al. Population-Based Norms for the Mini-Mental State Examination by Age and Educational Level. JAMA. 1993;269;(18):2386-2391. doi: 10.1001/jama.1993.03500180078038
  37. Wahlund LO, Barthof F, Fazekas F, et al. European Task Force on Age-Related Changes). Related changes in the White matter. A new scale for assessing age-related white matter changes, applicable to MRI and CT. Stroke. 2001;32(6):1318-22. doi: 10.1161/01.str.32.6.1318
  38. Scheltens P, Launer LJ, Barkhof F, et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol. 1995;242(9):557-60. DOI: https://doi.org/10.1007/BF00868807
  39. Koedam EL, Lehmann M, van der Flier WM, et. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618-25. doi: 10.1007/s00330-011-2205-4
  40. Sarazin M, de Souza LK, Leherici S, Dubois B. Clinical and research criteria for the diagnosis of Alzheimer’s disease. Neuroimaging Clinics of North America. 2012;22(1):23-32. doi: 10.1016/j.nic.2011.11.004

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure 1. Boxplots comparing the neuropsychological examination data of the two identified variants of MCI.

Download (1MB)

Copyright (c) 2025 Shubina K.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-65957 от 06 июня 2016 г.